ETON

Eton Pharmaceuticals, Inc.

A maker of rare-disease treatments for children and adults, Eton Pharmaceuticals markets FDA-approved products including INCRELEX for growth disorders and ALKINDI SPRINKLE, a first-of-its-kind granular hydrocortisone for kids with adrenal insufficiency. Born in 2017 as a spinoff from Imprimis Pharmaceuticals, the Deer Park, Illinois company reworks existing medicines into friendlier forms—like a needle-free ZENEO autoinjector that blasts an emergency dose through the skin in a fraction of a second.

CUSIP: 29772L108HealthcareUS1 holder

Ownership Activity Financials Filings

ETON

ETON

Results of Operations and Financial Condition

Entry into a Material Definitive Agreement

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements

Other Events

Submission of Matters to a Vote of Security Holders

Entry into a Material Definitive Agreement

Results of Operations and Financial Condition

Other Events